Immunization, Hib3 in El Salvador
El Salvador: Immunization, Hib3 was 95.0% in 2024. ▲ Rising
Immunization, Hib3 in El Salvador, 2002–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
El Salvador recorded 95.0% for immunization, hib3 in 2024.
That represents a change of down 1.0% on the previous year and up 1.1% over ten years.
Over the whole period, immunization, hib3 in El Salvador peaked at 99.0% in 2007 and was at its lowest, 81.0%, in 2002.
That places El Salvador 56th out of 191 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 23 years of available data.
Immunization, Hib3 in El Salvador, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2002 | 81.0% | — |
| 2003 | 94.0% | +16.0% |
| 2004 | 90.0% | -4.3% |
| 2005 | 89.0% | -1.1% |
| 2006 | 96.0% | +7.9% |
| 2007 | 99.0% | +3.1% |
| 2008 | 98.0% | -1.0% |
| 2009 | 91.0% | -7.1% |
| 2010 | 89.0% | -2.2% |
| 2011 | 89.0% | +0.0% |
| 2012 | 92.0% | +3.4% |
| 2013 | 92.0% | +0.0% |
| 2014 | 94.0% | +2.2% |
| 2015 | 94.0% | +0.0% |
| 2016 | 98.0% | +4.3% |
| 2017 | 92.0% | -6.1% |
| 2018 | 89.0% | -3.3% |
| 2019 | 96.0% | +7.9% |
| 2020 | 89.0% | -7.3% |
| 2021 | 97.0% | +9.0% |
| 2022 | 95.0% | -2.1% |
| 2023 | 96.0% | +1.1% |
| 2024 | 95.0% | -1.0% |
El Salvador compared with similar countries
- El Salvador's 95.0% is above the median for upper middle income countries, which is 91.0%, 1.0× the median. (57 countries reporting)
- El Salvador's 95.0% is above the median for Latin America & Caribbean, which is 90.0%, 1.1× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 92.2% | 81.0% | 99.0% | 8 |
| 2010s | 92.5% | 89.0% | 98.0% | 10 |
| 2020s | 94.4% | 89.0% | 97.0% | 5 |
Countries ranked near El Salvador
More health data for El Salvador
- Un projection of annual infant deaths, annual growth rate -1.89 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4574 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,537 deaths per 1,000 people (2090)
- Number of infants who die before age 1 104 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.9135 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0374 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8849 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in El Salvador?
- Immunization, hib3 in El Salvador was 95.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in El Salvador?
- The highest recorded value was 99.0% in 2007.
- What is the lowest immunization, hib3 recorded in El Salvador?
- The lowest recorded value was 81.0% in 2002.
- How does El Salvador rank for immunization, hib3?
- El Salvador ranks 56th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in El Salvador?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is rising.
- Where does this El Salvador data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.